232 related articles for article (PubMed ID: 14993244)
1. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis despite lower apolipoprotein B-containing lipoproteins.
Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; van Tol A
J Lipid Res; 2004 May; 45(5):805-11. PubMed ID: 14993244
[TBL] [Abstract][Full Text] [Related]
2. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion.
Lie J; de Crom R; van Gent T; van Haperen R; Scheek L; Lankhuizen I; van Tol A
J Lipid Res; 2002 Nov; 43(11):1875-80. PubMed ID: 12401886
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.
Lie J; de Crom R; Jauhiainen M; van Gent T; van Haperen R; Scheek L; Jansen H; Ehnholm C; van Tol A
Biochem J; 2001 Dec; 360(Pt 2):379-85. PubMed ID: 11716766
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein.
van Haperen R; van Tol A; van Gent T; Scheek L; Visser P; van der Kamp A; Grosveld F; de Crom R
J Biol Chem; 2002 Dec; 277(50):48938-43. PubMed ID: 12372822
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
Riemens S; van Tol A; Sluiter W; Dullaart R
Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
7. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
8. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
Jiang XC; Bruce C; Mar J; Lin M; Ji Y; Francone OL; Tall AR
J Clin Invest; 1999 Mar; 103(6):907-14. PubMed ID: 10079112
[TBL] [Abstract][Full Text] [Related]
9. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in atherosclerosis in mice with elevated phospholipid transfer protein activity are related to decreased plasma high density lipoproteins and not to increased production of triglycerides.
Lie J; Moerland M; van Gent T; van Haperen R; Scheek L; Sadeghi-Niaraki F; de Crom R; van Tol A
Biochim Biophys Acta; 2006 Sep; 1761(9):1070-7. PubMed ID: 16935026
[TBL] [Abstract][Full Text] [Related]
11. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
Riemens SC; Van Tol A; Stulp BK; Dullaart RP
J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.
Bruce C; Chouinard RA; Tall AR
Annu Rev Nutr; 1998; 18():297-330. PubMed ID: 9706227
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.
van Haperen R; Samyn H; Moerland M; van Gent T; Peeters M; Grosveld F; van Tol A; de Crom R
PLoS One; 2008 May; 3(5):e2255. PubMed ID: 18509527
[TBL] [Abstract][Full Text] [Related]
14. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers.
Liinamaa MJ; Hannuksela ML; Kesäniemi YA; Savolainen MJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2940-7. PubMed ID: 9409280
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo.
Kawano K; Qin SC; Lin M; Tall AR; Jiang XC
J Biol Chem; 2000 Sep; 275(38):29477-81. PubMed ID: 10893412
[TBL] [Abstract][Full Text] [Related]
16. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression.
Yang XP; Yan D; Qiao C; Liu RJ; Chen JG; Li J; Schneider M; Lagrost L; Xiao X; Jiang XC
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1601-7. PubMed ID: 12855484
[TBL] [Abstract][Full Text] [Related]
17. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.
Cheung MC; Wolfbauer G; Albers JJ
Biochim Biophys Acta; 1996 Sep; 1303(2):103-10. PubMed ID: 8856039
[TBL] [Abstract][Full Text] [Related]
18. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
Moerland M; Samyn H; van Gent T; van Haperen R; Dallinga-Thie G; Grosveld F; van Tol A; de Crom R
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1277-82. PubMed ID: 18421000
[TBL] [Abstract][Full Text] [Related]
19. Influence of the electrostatic charge of lipoprotein particles on the activity of the human plasma phospholipid transfer protein.
Desrumaux C; Athias A; Masson D; Gambert P; Lallemant C; Lagrost L
J Lipid Res; 1998 Jan; 39(1):131-42. PubMed ID: 9469592
[TBL] [Abstract][Full Text] [Related]
20. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]